SAN DIEGO, Nov. 11, 2010 /PRNewswire/ — Althea Technologies,
Inc., a leading provider of contract development and manufacturing
services for biopharmaceutical and parenteral products, announced
today that Rick Hancock has been
appointed President of the company. Mr. Hancock brings
twenty-seven years of industry experience and detailed working
knowledge of Althea’s operations to lead the company into the
future. Mr. Hancock will lead the company’s expansion of its
commercial contract manufacturing services.
Dr. Magda Marquet, Co-Founder and Co-Chairman of the Board,
commented, “I am very confident that Rick’s proven track record and
leadership style will be integral to Althea’s growth and success as
we continue to expand our business into commercial operations.
I am delighted to see Rick appointed as President.”
Mr. Hancock was Althea’s Chief Operating Officer from 1998 to
2007. In addition, he served as Althea’s Executive Vice President,
Europe to expand Althea’s global presence. During his tenure as
Althea’s COO, Rick was instrumental in growing the company from a
small group of scientists and manufacturing staff to a leading
contract manufacturing organization. In addition, Mr. Hancock
has a very strong background in process development and GMP
manufacturing dating back to his tenure at Hybritech, The Immune
Response Corporation and Genetics Institute.
Commenting on the contributions of his predeces